
Tessera Therapeutics
Developer of a gene writing technology designed to make permanent small and large alterations to the human genome. The company's technology helps scientists and clinicians with the ability to write sm...
Valuation
$0
Share Price
N/A
Total Raised
$630M
Last Round
N/A